High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
about
Validation of Nomograms for Survival and Metastases after Hysterectomy and Adjuvant Therapy in Uterine Cervical Cancer with Risk Factors.IER5 as a promising predictive marker promotes irradiation-induced apoptosis in cervical cancer tissues from patients undergoing chemoradiotherapyClinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer.Clinical outcome observation of preoperative concurrent chemoradiotherapy/radiotherapy alone in 174 Chinese patients with local advanced cervical carcinoma.Comparison of concurrent chemoradiotherapy followed by radical surgery and high-dose-rate intracavitary brachytherapy: a retrospective study of 240 patients with FIGO stage IIB cervical carcinoma.
P2860
High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
High-risk group for locoregion ...... concurrent chemoradiotherapy.
@en
High-risk group for locoregion ...... concurrent chemoradiotherapy.
@nl
type
label
High-risk group for locoregion ...... concurrent chemoradiotherapy.
@en
High-risk group for locoregion ...... concurrent chemoradiotherapy.
@nl
prefLabel
High-risk group for locoregion ...... concurrent chemoradiotherapy.
@en
High-risk group for locoregion ...... concurrent chemoradiotherapy.
@nl
P2093
P1433
P1476
High-risk group for locoregion ...... h concurrent chemoradiotherapy
@en
P2093
Kazuhiko Ogawa
Makoto Hirakawa
Morihiko Inamine
Sadayuki Murayama
Takafumi Toita
Wataru Kudaka
Yoichi Aoki
Yutaka Nagai
P304
P407
P577
2011-04-01T00:00:00Z